Q1-Q5C - EWG WorkPlan - 2023 - 0301

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

ICH Q1/Q5C EWG Work Plan

March 01, 2023

Topic Adoption date: June 2022


Rapporteur: Ms. Megan McMahon, PhRMA
Regulatory Chair: Dr. Ashutosh Rao, FDA, United States
Last Face-to-Face Meeting: Incheon, Republic of Korea, November 2022

1. Key milestones

1.a. Current status of key milestones


Past
completion date Milestone
Nov. 2022 Concept paper endorsement
Nov. 2022 Business plan endorsement
Nov. 2022 Establishment of EWG

1.b. Future anticipated key milestones


Expected future
completion date Milestone
Dec. 2024 Step 1 Sign-off
Dec. 2025 Step 4 Adoption, Completion of Training Materials

2. Timeline for specific tasks

Beginning End
date date Task / Activity Details
Dec. 2022 Feb. 2023 Define Guideline Sub-teams identify what initial content
revisions/initial drafts to drafts will be available for constituency
be completed Q1 2023. review by May 2023.

1
Dec. 2022 Feb. 2023 Deliver EWG aligned TOC. Alignment on organization of proposed
revision, including how to integrate
guidelines and manage annexes.

Feb. 2023 Mar. 2023 Section authoring by sub- Sub-teams will author sections in
teams, consulting as parallel, bringing drafted text to EWG
needed with EWG. for broader review/input.

Mar. 2023 Apr. 2023 Sub-teams collect and Sub-teams work to address EWG
address EWG feedback on feedback on completed text. Prepare
initial section drafts. initial draft sections for internal
constituency review.
May. 2023 May. 2023 Constituency review of Drafted components will be provided for
initial drafts of internal constituency review. Feedback
revised/new sections. will be requested by end of May.

May. 2023 Jun. 2023 Organize feedback into Identify feedback that requires
major and minor items. discussion by the full EWG and feedback
that may be managed at sub-team
level.
Jun. 2023 Jul. 2023 Discuss and address Sub-teams will address minor feedback
stakeholder feedback to sections. Feedback with broad
impact will be addressed within the
EWG.

You might also like